CMMB
Chemomab TherapeuticsCMMB
CMMB
0
Funds holding %
of 6,759 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
18% more capital invested
Capital invested by funds: $2.08M [Q1] → $2.45M (+$370K) [Q2]
7% more funds holding
Funds holding: 14 [Q1] → 15 (+1) [Q2]
0% more ownership
Funds ownership: 0.94% [Q1] → 0.94% (+0%) [Q2]
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Research analyst outlook
We haven’t received any recent analyst ratings for CMMB.
Financial journalist opinion
Charts implemented using Lightweight Charts™